Motivating HIV positive women to adhere to antiretroviral therapy and risk reduction behavior: the KHARMA Project.
Women comprise the fastest growing group of persons with AIDS. They are often diagnosed later in the disease, when antiretroviral therapy (ART) is strongly indicated. Antiretroviral therapy has transformed the course of HIV/AIDS to a treatable, chronic illness. This article provides a profile of women with HIV/AIDS and describes ART. Selected research related to adherence and motivation is summarized. Psychosocial and economic concerns specific to women, ART, adherence, and motivation are presented. The article reviews challenges for risk reduction behaviors for HIV+ women, such as sexual activity and substance abuse. The authors discuss the Keeping Health and Active with Risk reduction and Medication Adherence (KHARMA) Project, a research project in progress that was designed to promote adherence to both ART and risk reduction behaviors in HIV+ women. The study includes two groups: a motivational group intervention based on motivational interviewing and a health promotion program control group tailored to the needs of HIV+ women. A description of the tailored intervention and project update is included.
Holstad
Marcia McDonnell
MM
Family Community Health Department at the Nell Hodgson Woodruff School of Nursing at Emory University in Atlanta, Georgia, USA. nurmmcd@emory.edu
DiIorio
Colleen
C
Magowe
Mabel K M
MK
D000328:Adult; D023241:Antiretroviral Therapy, Highly Active / Q000451:nursing*; D015897:Comorbidity; D018562:Disease Transmission, Infectious / Q000517:prevention & control; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000451:nursing* / Q000517:prevention & control / Q000635:transmission; D007722:Health Knowledge, Attitudes, Practice; D006293:Health Promotion / Q000379:methods*; D006801:Humans; D007407:Interviews as Topic; D009042:Motivation; D010349:Patient Compliance; D015995:Prevalence; D040242:Risk Reduction Behavior; D012657:Self-Help Groups; D012737:Sex Factors; D012725:Sexual Behavior; D019966:Substance-Related Disorders / Q000453:epidemiology / Q000517:prevention & control; D014481:United States / Q000453:epidemiology